Business Models

Strategic Realignment for a Better Future

July 21, 2020

In adjusting to the long-term side-effects of the coronavirus pandemic, pharma companies will need to focus on change in three areas. Ben van der Schaaf and Aurelien Guichard report.

Better ESG Communication with Investors

June 12, 2020

Pharmaceutical Executive

Guidance addresses struggles in reporting non-financial performance.

How Biosimilar Manufacturers Can Get the Most Out of the "Patent Cliff"

May 21, 2020

As the number of biologics facing patent expiration in the US continues to rise, the market is further opening up to biosimilar manufacturers. George I'ons offers some pointers on how to secure an attractive market share during this time.

How to Ride the Data Wave When Launching a New Drug

May 21, 2020

How exactly do pharma companies account for a gap between their hopes for a new drug and reality? Peter Harbin reports.

Biopharma Sustainability Considered Essential

May 18, 2020

Pharmaceutical Executive

The commercial and social value of non-financial performance.

The Revenue Crises: Driving Pharma Companies to Change Revenue Management Tactics

April 24, 2020

Melonie Warfel discusses the challenges organizations are facing when it comes to revenue management and looks at the key areas to optimize.

Launch Strategies: What You Need to Know in 2020

April 08, 2020

In 2020 and beyond, succeeding in the new ecosystem means focusing on delivering value backed by data, tailored engagements with a diverse range of distinctly defined stakeholders, and monitoring the rapidly evolving healthcare space for new trends that will impact success.

Lean Thinking in Life Sciences: A Case for Enabling People

March 16, 2020

Fully understanding the construct of what it means to be lean can equip individual contributors, teams, and leaders to contribute to the fullest extent of their capabilities.

Access-Based Commercial (ABC) Strategy for Drug Commercialization

March 06, 2020

Wolfram Lux and Simon Seiter discuss the implications of Strategic Market Access on work and processes, and its role in product planning and drug development success.

Pharma Outsourcing: Keys to Productivity in 2020s

February 01, 2020

Pharmaceutical Executive

Eight lessons to drive better outsourcing decisions.